Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Arnulf

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 3, 2014
Human metapneumovirus pneumonia in patients with hematological malignanciesCendrine Godet, Jérôme Le Goff, Agnès Beby-Defaux, et al.
Haematologica|July 18, 2020
Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myelomaMaxime Fayon, Carolina Martinez-Cingolani, Audrey Abecassis, et al.
La Revue De Medecine Interne|August 8, 2024
[Serum hyperviscosity syndrome: Update 2024]Pierre-Edouard Debureaux, Nathalie Parquet, Anne C Brignier, et al.
Journal of Virology|July 1, 2006
Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entryDavid Ghez, Yves Lepelletier, Sophie Lambert, et al.
Leukemia|September 4, 2020
The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signallingAntoine David, Simone Zocchi, Alexis Talbot, et al.
Haematologica|July 3, 2025
Teclistamab for heavily pretreated relapsed / refractory POEMS syndromeAlexis Talbot, Nathalie Forgeard, Tristan Vaugeois, et al.
Oncogene|November 16, 2004
Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphomaRihab Nasr, Marwan E El-Sabban, José-Antonio Karam, et al.
British Journal of Haematology|December 17, 2019
Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literatureDikélélé Elessa, Alexis Talbot, Naëlle Lombion, et al.
Journal of Clinical Immunology|April 16, 2010
Immunoglobulin dosage and switch from intravenous to subcutaneous immunoglobulin replacement therapy in patients with primary hypogammaglobulinemia: decreasing dosage does not alter serum IgG levelsSylvain Thépot, Marion Malphettes, Anaëlle Gardeur, et al.
ESC Heart Failure|November 16, 2021
Thromboembolism and bleeding in systemic amyloidosis: a reviewMartin Nicol, Virginie Siguret, Giuseppe Vergaro, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 3, 2014
Human metapneumovirus pneumonia in patients with hematological malignanciesCendrine Godet, Jérôme Le Goff, Agnès Beby-Defaux, et al.
Haematologica|July 18, 2020
Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myelomaMaxime Fayon, Carolina Martinez-Cingolani, Audrey Abecassis, et al.
La Revue De Medecine Interne|August 8, 2024
[Serum hyperviscosity syndrome: Update 2024]Pierre-Edouard Debureaux, Nathalie Parquet, Anne C Brignier, et al.
Journal of Virology|July 1, 2006
Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entryDavid Ghez, Yves Lepelletier, Sophie Lambert, et al.
Leukemia|September 4, 2020
The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signallingAntoine David, Simone Zocchi, Alexis Talbot, et al.
Haematologica|July 3, 2025
Teclistamab for heavily pretreated relapsed / refractory POEMS syndromeAlexis Talbot, Nathalie Forgeard, Tristan Vaugeois, et al.
Oncogene|November 16, 2004
Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphomaRihab Nasr, Marwan E El-Sabban, José-Antonio Karam, et al.
British Journal of Haematology|December 17, 2019
Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literatureDikélélé Elessa, Alexis Talbot, Naëlle Lombion, et al.
Journal of Clinical Immunology|April 16, 2010
Immunoglobulin dosage and switch from intravenous to subcutaneous immunoglobulin replacement therapy in patients with primary hypogammaglobulinemia: decreasing dosage does not alter serum IgG levelsSylvain Thépot, Marion Malphettes, Anaëlle Gardeur, et al.
ESC Heart Failure|November 16, 2021
Thromboembolism and bleeding in systemic amyloidosis: a reviewMartin Nicol, Virginie Siguret, Giuseppe Vergaro, et al.
Pageof 16